Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
Danny Hsu, President of THANZ, reposted from ITP Australia and New Zealand on LinkedIn:
”Burden of disease in ITP patients is more significant than we think!
Thanks to the I-WISh study by Nichola Cooper, an excellent insight into what ITP patients go through.”
Quoting ITP Australia and New Zealand‘s post:
”Fatigue in ITP: A symptom that demands attention.
The original I‑WISh study highlighted a critical gap: while patients consistently report fatigue as one of the most disruptive aspects of Immune Thrombocytopenia (ITP), it is often under‑recognised in clinical practice.
“Fatigue has impacted my work, relationships, and daily routine.”
Now, I‑WISh 2.0 results are being finalised — with Australia included — offering fresh insights into patient and physician perspectives worldwide.
For healthcare professionals, this is a call to action: fatigue is not secondary.
It is central to the patient experience and must be addressed with empathy and integrated care strategies.
Explore the findings.”
Stay updated on all scientific advances with Hemostasis Today.
-
May 22, 2026, 06:11Mohamad Mohty: A New Open-Access Home for Hematology Case Reports
-
May 22, 2026, 05:23Carlos Silvestre-Roig։ Latest ATVB Publication Explores CCR2⁺ Neutrophils in Atherosclerosis
-
May 22, 2026, 01:15Reza Shojaei: How Rising Neurology Demand Is Reshaping Plasma Markets
-
May 22, 2026, 00:48Danielle Boyle: Honoured to Chair ITP Symposium at the EHA 2026
-
May 22, 2026, 00:40Quentin Van Thillo: UZ Leuven Is Recognized as an HHT Center of Excellence
-
May 21, 2026, 22:40David Cairns: Women Often Don’t Know Their Stroke Risk and That’s What We’re Trying to Change
-
May 21, 2026, 21:00Louise St. Germain Bannon: ETHA Launches European Antithrombotic Stewardship Survey Supported by ISTH
-
May 21, 2026, 20:07Stephanie Becker: ESOC 2026 Highlights Are Now Live in The Lancet Regional Health – Europe
-
May 21, 2026, 19:05Christopher Pittman: Why You Have 3 ‘Hearts’